loading
Precedente Chiudi:
$0.5094
Aprire:
$0.52
Volume 24 ore:
779.62K
Relative Volume:
0.48
Capitalizzazione di mercato:
$52.87M
Reddito:
-
Utile/perdita netta:
$-30.54M
Rapporto P/E:
-0.2627
EPS:
-1.98
Flusso di cassa netto:
$-18.30M
1 W Prestazione:
+17.81%
1M Prestazione:
+21.42%
6M Prestazione:
-49.25%
1 anno Prestazione:
+5.14%
Intervallo 1D:
Value
$0.50
$0.536
Intervallo di 1 settimana:
Value
$0.4191
$0.5461
Portata 52W:
Value
$0.202
$1.818

Unicycive Therapeutics Inc Stock (UNCY) Company Profile

Name
Nome
Unicycive Therapeutics Inc
Name
Telefono
650-384-0642
Name
Indirizzo
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
Name
Dipendente
14
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
UNCY's Discussions on Twitter

Confronta UNCY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
UNCY 0.524 52.87M 0 -30.54M -18.30M -1.98
VRTX 450.15 115.43B 10.63B -479.80M -1.35B 13.33
REGN 744.74 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 597.26 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.93 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.42 24.89B 3.30B -501.07M 1.03B 11.54

Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-04-04 Iniziato Piper Sandler Overweight

Unicycive Therapeutics Inc Borsa (UNCY) Ultime notizie

pulisher
07:07 AM

Unicycive Therapeutics to Participate in Two Upcoming Investor Conferences Including a Fireside Chat at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times

07:07 AM
pulisher
07:02 AM

Unicycive Therapeutics to Participate in Two Upcoming - GlobeNewswire

07:02 AM
pulisher
07:00 AM

Unicycive Therapeutics CEO to Present at Noble Capital and Piper Sandler Healthcare Conferences | UNCY Stock News - StockTitan

07:00 AM
pulisher
Nov 15, 2024

Logos Global Management LP Adjusts Stake in Unicycive Therapeuti - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

RA Capital Management's Strategic Acquisition of Unicycive Thera - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Great Point Partners LLC's Strategic Investment in Unicycive The - GuruFocus.com

Nov 15, 2024
pulisher
Nov 13, 2024

Walleye Capital LLC Acquires New Stake in Unicycive Therapeutics Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Unicycive's OLC Drug Gets FDA Review Date, Reports Strong Q3 Pipeline Progress | UNCY Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

USFDA accepts Shilpa Medicare CDMO partner Unicycive NDA for Oxylanthanum Carbonate - Medical Dialogues

Nov 13, 2024
pulisher
Nov 12, 2024

Unicycive Therapeutics (NASDAQ:UNCY) Given Buy Rating at HC Wainwright - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Unicycive shares hold as FDA accepts NDA for kidney treatment By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 12, 2024

Shilpa Medicare update on its CDMO partnerUnicycive Therapeutics - Business Standard

Nov 12, 2024
pulisher
Nov 12, 2024

Unicycive shares hold as FDA reviews new drug application By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 11, 2024

Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis - Marketscreener.com

Nov 11, 2024
pulisher
Nov 11, 2024

Unicycive eyes June FDA verdict for hyperphosphataemia drug - pharmaphorum

Nov 11, 2024
pulisher
Nov 11, 2024

Unicycive: FDA to Review Lead Drug Candidate for Hyperphosphatemia - MarketWatch

Nov 11, 2024
pulisher
Nov 11, 2024

Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis - The Manila Times

Nov 11, 2024
pulisher
Nov 11, 2024

Unicycive Therapeutics Announces U.S. FDA Acceptance of the - GlobeNewswire

Nov 11, 2024
pulisher
Nov 11, 2024

Unicycive's Kidney Disease Drug Gets FDA Review Date, Aims for 2025 Launch | UNCY Stock News - StockTitan

Nov 11, 2024
pulisher
Oct 29, 2024

Thinking about buying stock in Beyondspring, LAVA Therapeutics, - GuruFocus.com

Oct 29, 2024
pulisher
Oct 28, 2024

Unicycive Therapeutics Delivers Multiple Poster - GlobeNewswire

Oct 28, 2024
pulisher
Oct 28, 2024

Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024 - StockTitan

Oct 28, 2024
pulisher
Oct 16, 2024

Unicycive Therapeutics to Participate in a Fireside Chat at - GlobeNewswire

Oct 16, 2024
pulisher
Oct 16, 2024

Unicycive Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on October 17, 2024 - StockTitan

Oct 16, 2024
pulisher
Oct 16, 2024

This trade activity should not be overlooked: Unicycive Therapeutics Inc (UNCY) - SETE News

Oct 16, 2024
pulisher
Oct 16, 2024

Unicycive Therapeutics, Inc. (NASDAQ:UNCY): Is Breakeven Near? - Simply Wall St

Oct 16, 2024
pulisher
Oct 15, 2024

A year in review: Unicycive Therapeutics Inc (UNCY)’s performance in the last year - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Unicycive to present kidney disease therapies at ASN Kidney Week - Investing.com

Oct 14, 2024
pulisher
Oct 14, 2024

Unicycive Therapeutics Inc’s Market Journey: Closing Strong at 0.37, Up 3.12 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

Unicycive to present kidney disease therapies at ASN Kidney Week By Investing.com - Investing.com South Africa

Oct 14, 2024
pulisher
Oct 14, 2024

UNCYUnicycive Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 14, 2024
pulisher
Oct 14, 2024

Unicycive Therapeutics Announces Late-Breaker Poster - GlobeNewswire

Oct 14, 2024
pulisher
Oct 14, 2024

Unicycive Therapeutics Announces Late-Breaker Poster Presentation on Oxylanthanum Carbonate (OLC) at the American Society of Nephrology (ASN) Kidney Week 2024 - Yahoo Finance

Oct 14, 2024
pulisher
Oct 12, 2024

Unicycive Therapeutics (UNCY) Price Target Increased by 21.14% to 5.41 - MSN

Oct 12, 2024
pulisher
Oct 11, 2024

Octagon Capital Advisors LP Acquires New Stake in Unicycive Therapeutics Inc - Yahoo Finance

Oct 11, 2024
pulisher
Oct 11, 2024

Octagon Capital Advisors LP Acquires New Stake in Unicycive Ther - GuruFocus.com

Oct 11, 2024
pulisher
Oct 10, 2024

H.C. Wainwright & Co. Shares Buy Rating on Biotech Co. - Streetwise Reports

Oct 10, 2024
pulisher
Oct 09, 2024

Unicycive reports successful phase 1 kidney drug trial - Investing.com

Oct 09, 2024
pulisher
Oct 09, 2024

Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers - The Manila Times

Oct 09, 2024
pulisher
Oct 09, 2024

Unicycive reports successful phase 1 kidney drug trial By Investing.com - Investing.com UK

Oct 09, 2024
pulisher
Oct 08, 2024

Unicycive Therapeutics Inc (UNCY) is looking forward to a strong quarter - SETE News

Oct 08, 2024
pulisher
Oct 07, 2024

UNCY’s earnings forecast for the current quarter - US Post News

Oct 07, 2024
pulisher
Oct 07, 2024

Ratio Analysis: Unpacking Unicycive Therapeutics Inc (UNCY)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 07, 2024
pulisher
Oct 02, 2024

Unicycive Therapeutics Inc: Weathering Stock Market Storms with 35.62M Market Cap - The InvestChronicle

Oct 02, 2024
pulisher
Oct 01, 2024

Get in on Unicycive Therapeutics Inc’s (UNCY) buy-in window today! - SETE News

Oct 01, 2024
pulisher
Sep 30, 2024

Unicycive Therapeutics' SWOT analysis: stock potential in kidney disease market - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Was anything positive for Unicycive Therapeutics Inc (UNCY) stock last session? - US Post News

Sep 30, 2024
pulisher
Sep 25, 2024

What is Unicycive Therapeutics Inc (UNCY) Stock Return on Shareholders’ Capital? - SETE News

Sep 25, 2024
pulisher
Sep 25, 2024

Market Recap Check: Unicycive Therapeutics Inc (UNCY)’s Positive Finish at 0.44, Up/Down 2.82 - The Dwinnex

Sep 25, 2024
pulisher
Sep 24, 2024

Unicycive Therapeutics to Participate in a Fireside Chat at the Virtual Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - ForexTV.com

Sep 24, 2024

Unicycive Therapeutics Inc Azioni (UNCY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):